Steris Plc STE
Revenue Intelligence Report • 24 quarters of SEC filing data • Updated 2026-03-15
Steris Plc has a forecasted full-year revenue of $6.1B, a +6.6% year-over-year change, based on 24 quarters of SEC filing data. Key revenue drivers include R&D (elasticity 2.34x) and SG&A (elasticity 0.55x). The ARDL model achieves strong accuracy at 1.7% MAPE.
Investment Thesis
Our ARDL model tracks Steris Plc's revenue with exceptional precision (1.7% MAPE), indicating highly predictable cash flows. R&D investment shows a 2.34x multiplier — each 1% increase in R&D spend is associated with a 2.34% revenue increase, signaling strong innovation-to-revenue conversion. Sales & marketing spend shows a 0.55x elasticity, suggesting effective go-to-market execution.
Revenue Forecast
Quarterly Detail
| Quarter | Model Forecast | Actual | 95% Range | YoY Growth | Status |
|---|---|---|---|---|---|
| Q4 2025 | $1.4B | $1.5B | $1.3B – $1.4B | +4.2% | ✗ Outside range |
| Q2 2026 | $1.6B | $1.5B – $1.7B | +14.3% | ||
| Q3 2026 | $1.4B | $1.3B – $1.5B | +1.7% | ||
| Q4 2026 | $1.6B | $1.5B – $1.7B | +8.8% | ||
| Q1 2027 | $1.5B | $1.4B – $1.7B | +2.1% |
Seasonal Factors
| Fiscal Quarter | Seasonal Factor | vs Trend | Interpretation | Obs. |
|---|---|---|---|---|
| FQ1 (Sep–Nov) | 0.9927 | -0.7% | In line with trend | 7 |
| FQ2 (Dec–Feb) | 1.0113 | +1.1% | In line with trend | 7 |
| FQ3 (Mar–May) | 1.0 | +0.0% | In line with trend | 0 |
| FQ4 (Jun–Aug) | 0.9966 | -0.3% | In line with trend | 6 |
How Spending Drives Revenue
Want this analysis for your portfolio?
I build custom revenue intelligence reports for investors and companies using SEC filing data, econometric modeling, and AI-powered insights.
Get in Touch